Stocks making the biggest moves in the premarket: Peloton, Novavax, Vroom and more

cnbc.com:

Take a look at some of the biggest movers in the premarket:

Peloton (PTON) – Peloton shares plunged 25.8% in the premarket after the fitness equipment maker reported a larger-than-expected quarterly loss and projected current-quarter revenue below estimates due to softening demand.

Novavax (NVAX) – Novavax sank 23% in premarket trading after the vaccine maker missed both top and bottom line estimates for its latest quarter. The miss comes as Novavax shipped just 31 million Covid-19 vaccine doses during the quarter, putting it well off the pace of its projected 2 billion shots for 2022. Novavax reiterated its prior 2022 revenue forecast, however, saying it expected vaccine sales to accelerate during the current quarter.

Vroom (VRM) – Vroom surged 38% in premarket trading after the online used-vehicle seller posted a smaller than expected quarterly loss and revenue that exceeded analyst estimates. Vroom also announced that chief operating officer Thomas Shortt would become CEO, replacing Paul Hennessey, as well as unveiling a restructuring that will eliminate about 270 jobs.

Biohaven Pharmaceutical (BHVN) – The migraine drugmaker agreed to be bought by Pfizer (PFE) in a deal worth $11.6 billion, resulting in a 72% premarket surge in its shares. Biohaven shareholders will receive $148.50 per share in cash, plus half a share in a new publicly traded company that will hold some of the Biohaven drugs still in development. Pfizer, which had a 2.6% stake in Biohaven prior to the deal announcement, fell 1.4%.

Aramark (ARMK) – The food services company's shares gained 2.3% in the premarket, following news that it would separate its uniform services unit into a separate company. Separately, Aramark reported quarterly profit that